Zobrazeno 1 - 10
of 27
pro vyhledávání: '"John Oxford"'
Autor:
Ariel Beresniak, Christian Napoli, John Oxford, Alejandra Daruich, Laurent Niddam, Gérard Duru, Alberto E. Tozzi, Marta Ciofi degli Atti, Danielle Dupont, Caterina Rizzo, Dominique Bremond-Gignac
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess the cost-effectiveness of existing public health measures against human influenza
Externí odkaz:
https://doaj.org/article/9d5e2d32e0ff4174a782671a3ccfd9e3
Autor:
John Oxford
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 1, Pp 11-14 (2017)
Externí odkaz:
https://doaj.org/article/c1cb8cd70a8748299c5f774777fdd232
Publikováno v:
Materials, Vol 8, Iss 4, Pp 1966-1975 (2015)
To formulate an alginate dental impression material with virucidal properties, experimental alginate dental impression materials were developed and the formulations adjusted in order to study the effect on pH profiles during setting. Commercially ava
Externí odkaz:
https://doaj.org/article/029e03a2575b467bace223911bd61c43
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0159551 (2016)
A substantial proportion of the total infectious disease burden world-wide is due to person-to-person spread of pathogens within households. A questionnaire-based survey on the determinants of hand-washing with soap and cleaning of household surfaces
Externí odkaz:
https://doaj.org/article/390a701d63394b45947bc5de6949d119
Autor:
Julia Romanova, Brigitte M Krenn, Markus Wolschek, Boris Ferko, Ekaterina Romanovskaja-Romanko, Alexander Morokutti, Anna-Polina Shurygina, Sabine Nakowitsch, Tanja Ruthsatz, Bettina Kiefmann, Ulrich König, Michael Bergmann, Monika Sachet, Shobana Balasingam, Alexander Mann, John Oxford, Martin Slais, Oleg Kiselev, Thomas Muster, Andrej Egorov
Publikováno v:
PLoS ONE, Vol 4, Iss 6, p e5984 (2009)
BACKGROUND:We developed a novel intranasal influenza vaccine approach that is based on the construction of replication-deficient vaccine viruses that lack the entire NS1 gene (DeltaNS1 virus). We previously showed that these viruses undergo abortive
Externí odkaz:
https://doaj.org/article/b3e0973ffb1a4402a23935312dac8bf4
Autor:
Ariel Beresniak, Christian Napoli, John Oxford, Alejandra Daruich, Laurent Niddam MA, Gérard Duru, Alberto E Tozzi, Marta Ciofi Atti, Danielle Dupont, Dominique Bremond-Gignac, Caterina Rizzo
Background: The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess and compare the cost-effectiveness of existing public health measures against human influ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0686f647780bb78980241d54005f7e5
https://doi.org/10.21203/rs.3.rs-1603860/v1
https://doi.org/10.21203/rs.3.rs-1603860/v1
Autor:
Rayaj Ahamed, Ebonni Fisher, Karelle S. Aiken, Brandi Womack, Morgan Hudson-Davis, John Oxford, Kristina Deveaux, Laura Gessner
Publikováno v:
hc. 17:227-231
Single isomers of the furanylidene system 8 were synthesized in four steps. The synthesis begins with the dianion of β-keto carbonyls and culminates in a mild, tandem desilylation-cyclization reaction using tosylic acid. Compounds synthesized in thi
We reviewed the epidemiology, clinical characteristics, disease severity, and economic burden of influenza B as reported in the peer-reviewed published literature. We used MEDLINE to perform a systematic literature review of peer-reviewed, English-la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a913e00ddebe4e16ff2fab102cb3ea23
https://europepmc.org/articles/PMC3673513/
https://europepmc.org/articles/PMC3673513/
Autor:
Fiona, Gaughran, Rebecca, Walwyn, Rob, Lambkin-Williams, Paul, Whelan, Katherine, Chatterton, John, Oxford, Alastair, Macdonald
Publikováno v:
Journal of the American Geriatrics Society. 55(12)
To determine whether assessing seroprotection after influenza vaccine and administering booster vaccination where not achieved reduces hospitalization and death. To estimate the overall seroprotection rate of influenza vaccine.A two-arm, partially bl